每经AI快讯，今天国际（SZ 300532，收盘价：12.35元）11月14日晚间发布公告称，公司第五届第二十 次董事会会议于2025年11月14日以通讯表决方式召开。会议审议了《关于作废2021年限制性股票激励计 划部分已授予尚未归属的限制性股票的议案》等文件。 截至发稿，今天国际市值为56亿元。 每经头条（nbdtoutiao）——展望"十五五"|专访财科院院长杨志勇：遏制地方政府新增隐性债务，债务 信息要透明，尽可能降低利息成本 （记者 王晓波） 2025年1至6月份，今天国际的营业收入构成为：加工制造业占比98.6%，其他业务占比1.4%。 ...

格隆汇11月14日丨金盘科技(688676.SH)公布，公司于2025年11月14日召开第三届董事会第二十九次会 议，审议通过了《关于向2025年限制性股票激励计划激励对象首次授予限制性股票的议案》，同意并确 定公司本次激励计划首次授予日为2025年11月14日，向符合授予条件的391名激励对象首次授予400.00 万股限制性股票，授予价格为45.89元/股。 ...

金盘科技公告称，公司实施限制性股票激励计划，拟授予权益总计500万股，占当前公司总股本的 1.087%。其中，首次授予400万股，占比80%，涉及董事、高管、核心技术人员、中层管理人员及核心 业务骨干等；预留100万股，占比20%。激励对象包括轮值总裁杨霞玲获授15万股、高级副总裁栗记涛 等多人获授不同数量股票。预留部分激励对象将在计划经股东会审议通过后12个月内确定，超期未明确 则预留权益失效。 ...

Group 1 - The core point of the article is that DiAo Micro (SH 688381) announced the convening of its 20th meeting of the second board of directors on November 14, 2025, to review the proposal for adjusting the grant price of the 2024 restricted stock incentive plan [1] - For the year 2024, DiAo Micro's revenue composition is entirely from integrated circuits, accounting for 100.0% [1] - As of the time of reporting, DiAo Micro has a market capitalization of 5.9 billion yuan [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 重要内容提示： 根据中国证监会《上市公司股权激励管理办法》、深圳证券交易所、中国证券登记结算有限责任公司深 圳分公司有关规则的规定，安徽芯瑞达科技股份有限公司（以下简称"公司""芯瑞达"）完成了2025年限 制性股票激励计划（以下简称"本期激励计划"、"激励计划"）的授予登记工作，具体情况公告如下： 一、本期激励计划已履行的相关审批程序 （一）2025年4月11日，公司召开董事会薪酬与考核委员会2025年第一次会议审议通过，审议通过了 《关于公司〈2025年限制性股票激励计划（草案）〉及其摘要的议案》《关于公司〈2025年限制性股票 激励计划实施考核管理办法〉的议案》。 （二）2025年4月22日，公司第三届董事会第十八次会议审议通过了《关于公司〈2025年限制性股票激 励计划（草案）〉及其摘要的议案》《关于公司〈2025年限制性股票激励计划实施考核管理办法〉的议 案》《关于提请股东大会授权董事会办理公司2025年限制性股票激励计划有关事宜的议案》，公司第三 届监 ...

Core Viewpoint - Jiangsu Maxinlin Aviation Technology Co., Ltd. has announced the results of the first vesting period of its 2024 restricted stock incentive plan, with 1,425,000 shares set to be listed on November 18, 2025 [2][4]. Summary by Sections Stock Listing and Incentive Plan - The stock listing type is for equity incentive shares, with a total of 1,425,000 shares to be listed [2][3]. - The shares will be available for trading starting November 18, 2025 [4]. Decision-Making Process and Disclosure - On August 28, 2024, the company held a board meeting to approve the incentive plan and its management measures [6]. - The company conducted a public announcement regarding the independent directors' solicitation of voting rights on August 29, 2024 [5]. - The names and positions of the incentive plan participants were publicly disclosed from August 29 to September 7, 2024, with no objections received [5]. Vesting Details - A total of 24 individuals will benefit from the stock vesting, as one participant lost eligibility due to resignation [8]. - The shares are sourced from the company's A-share common stock issued to the incentive participants [8]. Capital Changes and Financial Impact - Following the vesting, the company's total share capital will increase from 145,426,667 shares to 146,851,667 shares [9]. - The new shares represent approximately 0.98% of the total shares before vesting, which will dilute the earnings per share but will not significantly impact the company's financial status [11]. Verification and Registration - The verification report by Lianda Accounting Firm confirmed that the company received a total of RMB 18,525,000 from the 24 participants, with RMB 1,425,000 as registered capital [10]. - The share registration procedures were completed on November 12, 2025 [10].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600216 证券简称：浙江医药 公告编号：2025-043 浙江医药股份有限公司关于2025年限制性股票激励计划内幕信息知情人买卖公司股票情况的自查报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 浙江医药股份有限公司（以下简称"公司"）于2025年10月27日召开第十届八次董事会会议，审议通过了 《关于〈浙江医药股份有限公司2025年限制性股票激励计划（草案）〉及其摘要的议案》等关于公司 2025年限制性股票激励计划（以下简称"本激励计划"）的相关议案，并于2025年10月28日在上海证券交 易所网站（www.sse.com.cn）披露了相关公告。 根据《上市公司股权激励管理办法》《上市公司信息披露管理办法》等有关法律、法规、部门规章、规 范性文件以及公司相关管理制度的规定，公司对本激励计划采取了充分必要的保密措施，并对本激励计 划的内幕信息知情人进行了登记。根据《上市公司股权激励管理办法》，公司通过中国证券登记结算有 限责任公司上海分公司（以下简称"中登公司 ...

Core Viewpoint - The company has announced the verification and public disclosure of the list of incentive recipients for its 2025 restricted stock incentive plan, ensuring compliance with relevant regulations and internal procedures [1][7]. Group 1: Public Disclosure and Verification Process - The company disclosed the draft of the 2025 restricted stock incentive plan and related documents on October 28, 2025, on the Shanghai Stock Exchange website [1][9]. - The public disclosure included the names and positions of the proposed incentive recipients, with a public notice period from October 31 to November 10, 2025, lasting no less than 10 days [1][9]. - Feedback from employees was collected during the public notice period, with one inquiry received and resolved, confirming no objections from other employees [1][9]. Group 2: Verification by Supervisory Board - The supervisory board verified the list of proposed incentive recipients, ensuring they met the criteria set forth in the management regulations and stock exchange rules [3][5]. - The proposed recipients do not fall under any disqualifying conditions as outlined in the management regulations, such as being deemed inappropriate candidates by regulatory bodies within the last 12 months [4][10]. - The recipients are identified as core personnel and others deemed necessary for motivation, excluding directors, supervisors, senior management, and significant shareholders [4][11]. Group 3: Verification by Compensation and Assessment Committee - The compensation and assessment committee conducted a similar verification process, confirming the legitimacy of the proposed recipients' qualifications [7][10]. - The committee also found that the proposed recipients met all necessary conditions and did not include any disqualified individuals as per the management regulations [10][12]. - The committee concluded that the proposed recipients' qualifications are valid and comply with all relevant laws and regulations [11][12].

Core Viewpoint - The company has decided to terminate the 2023 restricted stock incentive plan due to changes in the international economic and trade environment, as well as the need for strategic upgrades, which do not align with the current development needs of the company [1] Group 1 - The company will not proceed with the second and third phases of the restricted stock incentive plan, nor the reserved grants [1] - All restricted stocks granted under this incentive plan that have not yet been released from restrictions will be repurchased and canceled [1] - Related documents, including the implementation assessment management measures for the 2023 restricted stock incentive plan, will also be terminated [1]

Core Viewpoint - Songlin Technology (603992.SH) has decided to terminate its 2023 restricted stock incentive plan due to changes in the international economic and trade macro environment, as well as the company's strategic iteration and upgrade, which do not align with the current development needs of the company [1] Group 1 - The company believes that the current restricted stock incentive plan cannot meet the expected incentive goals and effects that align core employee work objectives with the company's development needs [1] - The decision includes the termination of the second and third phases of the incentive plan and the repurchase and cancellation of all restricted stocks that have been granted but not yet released from restrictions [1] - Related documents, including the "Implementation Assessment Management Measures for the 2023 Restricted Stock Incentive Plan of Xiamen Songlin Technology Co., Ltd.", will also be terminated [1]